Breast Cancer News and Research

Latest Breast Cancer News and Research

At local level, Komen affiliates express concern about decision

In California, seven Komen groups ask the national breast cancer group to reverse its funding decision. Others report concerns about community support for future money-raising activities.

6 Feb 2012

Viewpoints: Komen takes a lashing; Is the safety net really intact?; Romney assails HHS' rule on contraception

With its roster of corporate sponsors and the pink ribbons that lend a halo to almost any kind of product you can think of, the Susan G. Komen for the Cure foundation has a longstanding reputation as a staunch protector of women's health. That reputation suffered a grievous, perhaps mortal, wound this week from the news that Komen, the world's largest breast cancer organization, decided to betray that mission.

5 Feb 2012

Komen Foundation seeks to restore public support after ending cuts to Planned Parenthood

The prominent breast cancer charity announced Friday in a blog post that it had reversed this decision, which had stirred an outcry.

5 Feb 2012

Road Hockey To Conquer Cancer to kick off sophomore campaign on Feb. 7

It's an ordinary workday, and the lunch hour at Commerce Court is bustling with people. Wait a minute! What the heck is going on? Where did those hockey sticks come from? How did those nets appear? There's a road hockey game in progress!! But what the heck is with those guys wearing jockstraps over their suits? After an extraordinary inaugural event that raised $2.4 million for cancer research at The Princess Margaret Cancer Centre and Canadian Cancer Society, Road Hockey To Conquer Cancer will kick off its sophomore campaign with a spontaneous road hockey game on Tuesday, February 7, 2012 at 12:30pm in the courtyard at Commerce Court.

4 Feb 2012

New approach can solve treatment-resistant problem in cancers

Free-flowing cancer cells have been mapped with unprecedented accuracy in the bloodstream of patients with prostate, breast and pancreatic cancer, using a brand new approach, in an attempt to assess and control the disease as it spreads in real time through the body, and solve the problem of predicting response and resistance to therapies.

4 Feb 2012

Soy isoflavone supplements do not reduce breast cancer cell proliferation

Soy isoflavone supplements did not decrease breast cancer cell proliferation in a randomized clinical trial, according to a study published in Cancer Prevention Research, a journal of the American Association for Cancer Research.

4 Feb 2012

Positive updated results from Aeterna Zentaris' AEZS-108 Phase 1 trial on CRPC

Aeterna Zentaris Inc. today reported positive updated results for the Phase 1 portion of its ongoing Phase 1/2 study in castration- and taxane-resistant prostate cancer (CRPC) with AEZS-108 (zoptarelin doxorubicin), the Company's targeted cytotoxic luteinizing hormone-releasing hormone (LHRH) analog.

4 Feb 2012

VuCOMP receives PMA for M-Vu CAD system

VuCOMP, Inc., developer of computer-aided detection (CAD) systems for automatic analysis of medical imagery, is pleased to announce premarket approval (PMA) of M-Vu, a cutting-edge CAD system for film mammography.

3 Feb 2012

Exelixis reports preliminary data from cabozantinib phase 1b trial on RCC

Exelixis, Inc. today reported preliminary data from a cohort of heavily pretreated patients with metastatic refractory renal cell carcinoma (RCC) participating in an ongoing phase 1b trial of cabozantinib.

3 Feb 2012

MD Anderson study defines value in health care

A team from The University of Texas MD Anderson Cancer Center is receiving a national award for a research article tackling a question vital to the future of health care with reform regulations looming, competition growing and costs rising.

3 Feb 2012

Pertuzumab plus trastuzumab and docetaxel has advantages over current clinical gold-standard treatment

Roche/Genentech/Chugai's pertuzumab plus trastuzumab (Roche/Genentech/Chugai's Herceptin) and docetaxel (Sanofi's Taxotere, generics) will become Decision Resources' proprietary clinical gold-standard treatment for metastatic first-line HER2-positive breast cancer in 2015.

3 Feb 2012

Viewpoints: Censoring flu research; Assailing Komen's move to cut Planned Parenthood funding

In December, the National Science Advisory Board for Biosecurity made an unprecedented request: it asked the editors of the journals Nature and Science not to publish certain details in two papers describing experiments in which scientists created a highly transmissible form of the deadly H5N1 influenza virus. ... Such caution, though well intentioned, is misplaced.

3 Feb 2012

Uproar follows Komen-Planned Parenthood rift

Anti-abortion activists applaud the move, but many other women's health advocates are angered the well-known breast cancer advocacy group has opted against helping another prominent women's health organization.

3 Feb 2012

Komen Breast Cancer Foundation cuts grants, ties to Planned Parenthood

The Susan G. Komen for the Cure Foundation, a leading breast-cancer charity, will no longer give money to Planned Parenthood for breast cancer exams or education, it announced Tuesday. The rift comes from the political fight surrounding Planned Parenthood's abortion services.

2 Feb 2012

Cancer Genomics now available online

Genome Research publishes online and in print today a special issue entitled, "Cancer Genomics," highlighting insights gained form cutting-edge genomic and epigenomic analyses of cancer.

2 Feb 2012

Widely varying rates of repeat breast cancer surgery among surgeons: Study

According to a new study the number of repeat surgeries in women who had a breast tumor removed depends on their individual surgeons and medical centers and no clear reason for these differences are found.

1 Feb 2012

New York hospital offers at-home method for tissue expansion for breast reconstruction surgery

NewYork-Presbyterian Hospital/Columbia University Medical Center is the first hospital in the New York metro area to offer breast cancer survivors an at-home method for tissue expansion in preparation for breast reconstruction surgery. Patients use a remote control to gradually create a space within their chest wall for a breast implant.

1 Feb 2012

Study reveals substantial differences in rates of follow-up surgeries after partial mastectomy

A new study reveals substantial differences - by both surgeon and institution - in the rates of follow-up surgeries for women who underwent a partial mastectomy for treatment of breast cancer.

1 Feb 2012

Nearly one in four women have another surgery following partial mastectomy

Nearly one in four women who undergo a partial mastectomy for treatment of breast cancer have another surgery to remove additional tissue (reexcision), and there is substantial surgeon and institutional variation in the rate of reexcisions that cannot be explained by patients' clinical characteristics, according to a study in the February 1 issue of JAMA.

1 Feb 2012

General anesthesia may lower recurrence risk in patients with HCC

For patients undergoing a minimally invasive treatment for liver cancer, the risk of recurrent cancer appears lower with general anesthesia compared to regional (epidural) anesthesia, reports a study in the February issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society (IARS).

1 Feb 2012